SCOPUS 정보 검색 플랫폼

Volumn 117, Issue 4, 2016, Pages 611-616

Temporal Changes in Postdischarge Mortality Risk after Hospitalization for Heart Failure (from the EVEREST Trial)

(11) Cook, Thomas D a Greene, Stephen J b Kalogeropoulos, Andreas P c Fonarow, Gregg C d Zea, Ryan a Swedberg, Karl e Zannad, Faiez f Maggioni, Aldo P g Konstam, Marvin A h Gheorghiade, Mihai i Butler, Javed j

a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH (United States)

b DUKE UNIVERSITY MEDICAL CENTER (United States)

c EMORY UNIVERSITY SCHOOL OF MEDICINE (United States)

d UNIVERSITY OF CALIFORNIA (United States)

e UNIVERSITY OF GOTHENBURG (Sweden)

f UNIVERSITY HOSPITAL OF NANCY (France)

g ANMCO RESEARCH CENTER (Italy)

h TUFTS MEDICAL CENTER (United States)

i NORTHWESTERN UNIVERSITY (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TOLVAPTAN; BENZAZEPINE DERIVATIVE; VASOPRESSIN RECEPTOR ANTAGONIST;

AGED; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PATIENT RISK; POPULATION RISK; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; CAUSE OF DEATH; CLINICAL TRIAL; DOSE RESPONSE; EPIDEMIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; PROSPECTIVE STUDY; RISK ASSESSMENT; TRENDS; UNITED STATES;

AGED; ANTIDIURETIC HORMONE RECEPTOR ANTAGONISTS; BENZAZEPINES; CAUSE OF DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; UNITED STATES;

EID: 84958830961 PISSN: 00029149 EISSN: 18791913 Source Type: Journal
DOI: 10.1016/j.amjcard.2015.11.050 Document Type: Article

Times cited : (15)

References (16)

1
- 34748819364
- Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure
- S.D. Solomon, J. Dobson, S. Pocock, H. Skali, J.J. McMurray, C.B. Granger, S. Yusuf, K. Swedberg, J.B. Young, E.L. Michelson, and M.A. Pfeffer Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure Circulation 116 2007 1482 1487
- (2007) Circulation , vol.116 , pp. 1482-1487
- Solomon, S.D.¹ Dobson, J.² Pocock, S.³ Skali, H.⁴ McMurray, J.J.⁵ Granger, C.B.⁶ Yusuf, S.⁷ Swedberg, K.⁸ Young, J.B.⁹ Michelson, E.L.¹⁰ Pfeffer, M.A.¹¹

2
- 84880998969
- Risk following hospitalization in stable chronic systolic heart failure
- P. Abrahamsson, K. Swedberg, J.S. Borer, M. Bohm, L. Kober, M. Komajda, S.M. Lloyd, M. Metra, L. Tavazzi, and I. Ford Risk following hospitalization in stable chronic systolic heart failure Eur J Heart Fail 15 2013 885 891
- (2013) Eur J Heart Fail , vol.15 , pp. 885-891
- Abrahamsson, P.¹ Swedberg, K.² Borer, J.S.³ Bohm, M.⁴ Kober, L.⁵ Komajda, M.⁶ Lloyd, S.M.⁷ Metra, M.⁸ Tavazzi, L.⁹ Ford, I.¹⁰

3
- 84925857987
- The vulnerable phase after hospitalization for heart failure
- S.J. Greene, G.C. Fonarow, M. Vaduganathan, S.S. Khan, J. Butler, and M. Gheorghiade The vulnerable phase after hospitalization for heart failure Nat Rev Cardiol 12 2015 220 229
- (2015) Nat Rev Cardiol , vol.12 , pp. 220-229
- Greene, S.J.¹ Fonarow, G.C.² Vaduganathan, M.³ Khan, S.S.⁴ Butler, J.⁵ Gheorghiade, M.⁶

4
- 77950295232
- Critical elements of clinical follow-up after hospital discharge for heart failure: Insights from the EVEREST trial
- S.M. Dunlay, M. Gheorghiade, K.J. Reid, L.A. Allen, P.S. Chan, P.J. Hauptman, F. Zannad, A.P. Maggioni, K. Swedberg, M.A. Konstam, and J.A. Spertus Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial Eur J Heart Fail 12 2010 367 374
- (2010) Eur J Heart Fail , vol.12 , pp. 367-374
- Dunlay, S.M.¹ Gheorghiade, M.² Reid, K.J.³ Allen, L.A.⁴ Chan, P.S.⁵ Hauptman, P.J.⁶ Zannad, F.⁷ Maggioni, A.P.⁸ Swedberg, K.⁹ Konstam, M.A.¹⁰ Spertus, J.A.¹¹

5
- 84861553275
- A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: Analysis from the EVEREST trial
- M. Gheorghiade, P.S. Pang, A.P. Ambrosy, G. Lan, P. Schmidt, G. Filippatos, M. Konstam, K. Swedberg, T. Cook, B. Traver, A. Maggioni, J. Burnett, L. Grinfeld, J. Udelson, and F. Zannad A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial Heart Fail Rev 17 2012 485 509
- (2012) Heart Fail Rev , vol.17 , pp. 485-509
- Gheorghiade, M.¹ Pang, P.S.² Ambrosy, A.P.³ Lan, G.⁴ Schmidt, P.⁵ Filippatos, G.⁶ Konstam, M.⁷ Swedberg, K.⁸ Cook, T.⁹ Traver, B.¹⁰ Maggioni, A.¹¹ Burnett, J.¹² Grinfeld, L.¹³ Udelson, J.¹⁴ Zannad, F.¹⁵

6
- 84871927704
- Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: Correlation with outcomes
- M. Metra, G. Cotter, B.A. Davison, G.M. Felker, G. Filippatos, B.H. Greenberg, P. Ponikowski, E. Unemori, A.A. Voors, K.F. Adams Jr., M.I. Dorobantu, L. Grinfeld, G. Jondeau, A. Marmor, J. Masip, P.S. Pang, K. Werdan, M.F. Prescott, C. Edwards, S.L. Teichman, A. Trapani, C.A. Bush, R. Saini, C. Schumacher, T. Severin, and J.R. Teerlink Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes J Am Coll Cardiol 61 2013 196 206
- (2013) J Am Coll Cardiol , vol.61 , pp. 196-206
- Metra, M.¹ Cotter, G.² Davison, B.A.³ Felker, G.M.⁴ Filippatos, G.⁵ Greenberg, B.H.⁶ Ponikowski, P.⁷ Unemori, E.⁸ Voors, A.A.⁹ Adams, K.F.¹⁰ Dorobantu, M.I.¹¹ Grinfeld, L.¹² Jondeau, G.¹³ Marmor, A.¹⁴ Masip, J.¹⁵ Pang, P.S.¹⁶ Werdan, K.¹⁷ Prescott, M.F.¹⁸ Edwards, C.¹⁹ Teichman, S.L.²⁰ more..

7
- 33947713810
- Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial
- M.A. Konstam, M. Gheorghiade, J.C. Burnett Jr., L. Grinfeld, A.P. Maggioni, K. Swedberg, J.E. Udelson, F. Zannad, T. Cook, J. Ouyang, C. Zimmer, and C. Orlandi Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial JAMA 297 2007 1319 1331
- (2007) JAMA , vol.297 , pp. 1319-1331
- Konstam, M.A.¹ Gheorghiade, M.² Burnett, J.C.³ Grinfeld, L.⁴ Maggioni, A.P.⁵ Swedberg, K.⁶ Udelson, J.E.⁷ Zannad, F.⁸ Cook, T.⁹ Ouyang, J.¹⁰ Zimmer, C.¹¹ Orlandi, C.¹²

8
- 20944445209
- Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)
- M. Gheorghiade, C. Orlandi, J.C. Burnett, D. Demets, L. Grinfeld, A. Maggioni, K. Swedberg, J.E. Udelson, F. Zannad, C. Zimmer, and M.A. Konstam Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) J Card Fail 11 2005 260 269
- (2005) J Card Fail , vol.11 , pp. 260-269
- Gheorghiade, M.¹ Orlandi, C.² Burnett, J.C.³ Demets, D.⁴ Grinfeld, L.⁵ Maggioni, A.⁶ Swedberg, K.⁷ Udelson, J.E.⁸ Zannad, F.⁹ Zimmer, C.¹⁰ Konstam, M.A.¹¹

9
- 85088938629
- 2nd ed. J. Wiley Hoboken, N.J.
- J.D. Kalbfleisch, and R.L. Prentice The Statistical Analysis of Failure Time Data 2nd ed. 2002 J. Wiley Hoboken, N.J.
- (2002) The Statistical Analysis of Failure Time Data
- Kalbfleisch, J.D.¹ Prentice, R.L.²

10
- 84907416082
- Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction
- N.A. Bello, B. Claggett, A.S. Desai, J.J. McMurray, C.B. Granger, S. Yusuf, K. Swedberg, M.A. Pfeffer, and S.D. Solomon Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction Circ Heart Fail 7 2014 590 595
- (2014) Circ Heart Fail , vol.7 , pp. 590-595
- Bello, N.A.¹ Claggett, B.² Desai, A.S.³ McMurray, J.J.⁴ Granger, C.B.⁵ Yusuf, S.⁶ Swedberg, K.⁷ Pfeffer, M.A.⁸ Solomon, S.D.⁹

11
- 84929456255
- Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: Retrospective cohort study
- K. Dharmarajan, A.F. Hsieh, V.T. Kulkarni, Z. Lin, J.S. Ross, L.I. Horwitz, N. Kim, L.G. Suter, H. Lin, S.L. Normand, and H.M. Krumholz Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study BMJ 350 2015 h411
- (2015) BMJ , vol.350 , pp. h411
- Dharmarajan, K.¹ Hsieh, A.F.² Kulkarni, V.T.³ Lin, Z.⁴ Ross, J.S.⁵ Horwitz, L.I.⁶ Kim, N.⁷ Suter, L.G.⁸ Lin, H.⁹ Normand, S.L.¹⁰ Krumholz, H.M.¹¹

12
- 84899472608
- Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT
- H. Skali, E.M. Dwyer, R. Goldstein, M. Haigney, R. Krone, M. Kukin, E. Lichstein, S. McNitt, A.J. Moss, M.A. Pfeffer, and S.D. Solomon Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT Eur J Heart Fail 16 2014 560 565
- (2014) Eur J Heart Fail , vol.16 , pp. 560-565
- Skali, H.¹ Dwyer, E.M.² Goldstein, R.³ Haigney, M.⁴ Krone, R.⁵ Kukin, M.⁶ Lichstein, E.⁷ McNitt, S.⁸ Moss, A.J.⁹ Pfeffer, M.A.¹⁰ Solomon, S.D.¹¹

13
- 33644878739
- Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients
- S.D. Solomon, N. Anavekar, H. Skali, J.J. McMurray, K. Swedberg, S. Yusuf, C.B. Granger, E.L. Michelson, D. Wang, S. Pocock, and M.A. Pfeffer Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients Circulation 112 2005 3738 3744
- (2005) Circulation , vol.112 , pp. 3738-3744
- Solomon, S.D.¹ Anavekar, N.² Skali, H.³ McMurray, J.J.⁴ Swedberg, K.⁵ Yusuf, S.⁶ Granger, C.B.⁷ Michelson, E.L.⁸ Wang, D.⁹ Pocock, S.¹⁰ Pfeffer, M.A.¹¹

14
- 77953012147
- Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006
- H. Bueno, J.S. Ross, Y. Wang, J. Chen, M.T. Vidan, S.L. Normand, J.P. Curtis, E.E. Drye, J.H. Lichtman, P.S. Keenan, M. Kosiborod, and H.M. Krumholz Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006 JAMA 303 2010 2141 2147
- (2010) JAMA , vol.303 , pp. 2141-2147
- Bueno, H.¹ Ross, J.S.² Wang, Y.³ Chen, J.⁴ Vidan, M.T.⁵ Normand, S.L.⁶ Curtis, J.P.⁷ Drye, E.E.⁸ Lichtman, J.H.⁹ Keenan, P.S.¹⁰ Kosiborod, M.¹¹ Krumholz, H.M.¹²

15
- 84873098252
- The disconnect between phase II and phase III trials of drugs for heart failure
- M. Vaduganathan, S.J. Greene, A.P. Ambrosy, M. Gheorghiade, and J. Butler The disconnect between phase II and phase III trials of drugs for heart failure Nat Rev Cardiol 10 2013 85 97
- (2013) Nat Rev Cardiol , vol.10 , pp. 85-97
- Vaduganathan, M.¹ Greene, S.J.² Ambrosy, A.P.³ Gheorghiade, M.⁴ Butler, J.⁵

16
- 84873675486
- Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia
- H.M. Krumholz, Z. Lin, P.S. Keenan, J. Chen, J.S. Ross, E.E. Drye, S.M. Bernheim, Y. Wang, E.H. Bradley, L.F. Han, and S.L. Normand Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia JAMA 309 2013 587 593
- (2013) JAMA , vol.309 , pp. 587-593
- Krumholz, H.M.¹ Lin, Z.² Keenan, P.S.³ Chen, J.⁴ Ross, J.S.⁵ Drye, E.E.⁶ Bernheim, S.M.⁷ Wang, Y.⁸ Bradley, E.H.⁹ Han, L.F.¹⁰ Normand, S.L.¹¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.